Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 12/17/2024 at 14:30, 1 year 1 month ago

FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera
World Health Organization (WHO) elevates cholera to highest emergency level due to global resurgence. Crofelemer granted orphan-drug designation by FDA and EMA for cholera treatment

FDA Crofelemer Cholera Orphan-Drug Designation World Health Organization
BRIEF

published on 12/13/2024 at 16:05, 1 year 1 month ago

Ladenburg Thalmann to Host Scientific Showcase on Jaguar Health's Crofelemer

Crofelemer Jaguar Health Rare Diseases Napo Therapeutics Scientific Showcase
BRIEF

published on 12/13/2024 at 16:05, 1 year 1 month ago

Ladenburg Thalmann organise une exposition scientifique sur le Crofelemer de Jaguar Health

Crofelemer Maladies Rares Santé Jaguar Napo Thérapeutique Vitrine Scientifique
PRESS RELEASE

published on 12/13/2024 at 16:00, 1 year 1 month ago

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer
Jaguar Health, Inc. announces virtual event on crofelemer clinical development efforts for rare diseases MVID and SBS-IF. CEO awarded 'Best CEO BioPharmaceuticals of the Year'

Crofelemer Clinical Development Jaguar Health Rare Diseases MVID
BRIEF

published on 12/12/2024 at 15:05, 1 year 1 month ago

Le Crofelemer de Jaguar Health s'avère prometteur dans le traitement de la diarrhée liée à la thérapie contre le cancer

Crofelemer Essai Clinique Cancer Du Sein Diarrhée Liée Au Traitement Du Cancer SABCS
BRIEF

published on 12/12/2024 at 15:05, 1 year 1 month ago

Jaguar Health's Crofelemer Shows Promise in Treating Cancer Therapy-Related Diarrhea

Crofelemer Cancer Therapy-related Diarrhea Clinical Trial Breast Cancer SABCS
PRESS RELEASE

published on 12/12/2024 at 15:00, 1 year 1 month ago

Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Napo Pharmaceuticals presents statistically significant results of crofelemer in breast cancer patients for prophylaxis of CTD at SABCS. Study highlights impact of diarrhea in cancer treatment

Napo Pharmaceuticals Crofelemer Breast Cancer CTD SABCS
BRIEF

published on 12/09/2024 at 16:05, 1 year 1 month ago

Jaguar Health to Present Crofelemer Results at SABCS 2024

Crofelemer OnTarget Trial Breast Cancer CTD Prophylaxis SABCS 2024
BRIEF

published on 12/09/2024 at 16:05, 1 year 1 month ago

Jaguar Health présentera les résultats de Crofelemer au SABCS 2024

Crofelemer Essai OnTarget Cancer Du Sein SABCS 2024 Prophylaxie De La Maladie Du Tissu Conjonctif
PRESS RELEASE

published on 12/09/2024 at 16:00, 1 year 1 month ago

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)
Jaguar Health's Napo Pharmaceuticals to present data on crofelemer in breast cancer patients at SABCS 2024. Additional analyses ongoing. Patient advocacy program also announced

Napo Pharmaceuticals Crofelemer Jaguar Health Breast Cancer SABCS 2024

Accesswire

Published on 02/07/2026 at 01:00, 1 day 17 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 19 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 20 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 2 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 2 days 4 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 21 hours 22 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 1 hour ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 2 hours ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 22 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 2 days ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 days ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 2 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 days 2 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 10 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE